Skip to main content
NIH funding notice PAR-20-315

Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional)

Closed on September 30, 2023.

Posted
November 5, 2020
Close date
September 30, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $783,430 in first-year total cost, median $783,430.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 GRB-I (O1)]1

Most frequent institutions

  1. RUTGERS BIOMEDICAL AND HEALTH SCIENCES1
Competing awards under PAR-20-315 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023The Landscape of Tumor intrinsic Genetic Resistance to T cell Therapy1R00CA195682-02A1HINRICHS, CHRISTIANRUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ$783,430ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-20-315: Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional) | ScienceDex | ConductScience